Utah Cord Bank LLC – FDA Warning Letter, Feb 11, 2021
On May 11, 2021, the FDA issued a Warning Letter to Utah Cord Bank, LLC, following an inspection from February 1-11, 2021. The inspection revealed significant deviations from Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) regulations (21 CFR Part 1271), applicable to HCT/Ps recovered between May 25, 2005, and February 11, 2021.
Key violations include: 1. **Failure to Validate Processes (21 CFR 1271.230(a)):** The firm failed to validate manufacturing processes, including microbiological testing, to ensure prevention of contamination and communicable disease transmission. 2. **Inadequate Environmental Monitoring (21 CFR 1271.195(c)):** Environmental conditions were not adequately monitored where HCT/Ps were exposed to the environment during processing, potentially causing contamination. 3. **Lack of Established Procedures (21 CFR 1271.180(a)):** The firm failed to establish and maintain procedures for critical operations, including facilities, environmental control, equipment, supplies/reagents, processing, labeling, storage, and distribution. 4. **Failure to Maintain Complete Records (21 CFR 1271.270(a)):**
ID · 5d33db14-c1ce-447b-b250-13c21c72efb6
Full citation text and observation details available on the Dashboard.
- 483 - 2023-01-06
- WARNING_LETTER - 2021-02-11
- 483 - 2021-02-11
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.